From Mr I. Strachan, MRPharmS
SIR,—A tendency to tell others while failing to listen is a charge that
could be levelled against the majority. Listening to the views and opinions
of others is a quality the pharmaceutical industry has on occasions been challenged
with omitting from its marketing initiatives.
The announcement by Smithkline Beecham that it is reducing the price of its
flagship brand Niquitin, reflects the company’s desire to listen and respond
to the views of pharmacists and assistants alike. It is particularly gratifying
to observe the company respecting the sentiments of assistants in such a courageous
manner by boldly reducing its price in this way. I hope industry is encouraged
to nurture such partnerships by informing and involving the very people who
are ultimately incremental to the success of any new products where growth is
reliant upon the support of pharmacy.
Ian Strachan
Bury